Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Asset Writedowns and Impairment (2022 - 2025)

Proto Labs' Asset Writedowns and Impairment history spans 5 years, with the latest figure at -$448000.0 for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment fell 275.0% year-over-year to -$448000.0; the TTM value through Jun 2025 reached $704000.0, changed N/A, while the annual FY2024 figure was $256000.0, N/A changed from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was -$448000.0 at Proto Labs, down from $229000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.0 million in Q3 2022 and bottomed at -$2.8 million in Q4 2022.
  • The 3-year median for Asset Writedowns and Impairment is $224000.0 (2025), against an average of -$256000.0.
  • The largest YoY upside for Asset Writedowns and Impairment was 275.0% in 2025 against a maximum downside of 275.0% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at -$2.8 million in 2022, then surged by 109.01% to $256000.0 in 2024, then plummeted by 275.0% to -$448000.0 in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Asset Writedowns and Impairment are -$448000.0 (Q3 2025), $229000.0 (Q2 2025), and $219000.0 (Q1 2025).